OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE 12.5 mg/1

Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg/1 is a combination medication used to manage high blood pressure. This oral tablet combines two active ingredients to support cardiovascular health.

Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg/1 is commonly used for the treatment of hypertension, or high blood pressure. Olmesartan works by relaxing blood vessels, while hydrochlorothiazide helps the kidneys remove excess salt and water from the body. This dual-action approach is often recommended for individuals who need additional support in managing their blood pressure levels.

Common effects of Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg/1 may include dizziness, fatigue, and mild stomach discomfort. Some users might experience a dry cough or changes in electrolyte levels. These effects vary and are not experienced by everyone.

It is important to use Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg/1 as directed by a healthcare professional. Individuals with kidney disease, liver disease, or those who are pregnant should discuss potential risks with their doctor. Regular monitoring of blood pressure and electrolyte levels is recommended.

Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg/1 may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), lithium, and certain diabetes medications. Alcohol consumption should be limited, as it can exacerbate the effects of this medication. Always inform your healthcare provider about all medications you are taking.